文献
J-GLOBAL ID:202002258842745713
整理番号:20A2199952
Glecaprevir/Pibrentasvirによる治療の8週間は,C型肝炎ウイルス感染を伴う治療未経験患者の統合分析において安全かつ有効である【JST・京大機械翻訳】
Eight Weeks of Treatment With Glecaprevir/Pibrentasvir Is Safe and Efficacious in an Integrated Analysis of Treatment-Naieve Patients With Hepatitis C Virus Infection
著者 (17件):
Zuckerman Eli
(Liver Unit, Carmel Medical Center, Faculty of Medicine, Technion Institute, Haifa, Israel)
,
Gutierrez Julio A.
(Scripps Clinic, Center for Organ and Cell Transplantation, La Jolla, California)
,
Dylla Douglas E.
(AbbVie, Inc, North Chicago, Illinois)
,
de Ledinghen Victor
(Centre d’Investigation de la Fibrose Hepatique, Bordeaux University Hospital, Pessac, France; INSERM U1053, Bordeaux University, Bordeaux, France)
,
Muir Andrew J.
(Duke Clinical Research Institute, Durham, North Carolina)
,
Gschwantler Michael
(Department of Internal Medicine IV, Wilhelminenspital, Vienna, Austria)
,
Gschwantler Michael
(Sigmund Freud University, Vienna, Austria)
,
Puoti Massimo
(Niguarda ca Grande Hospital, Milan, Italy)
,
Caruntu Florin
(National Institute for Infectious Diseases “Prof. Matei Bals,” Bucharest, Romania)
,
Slim Jihad
(Infectious Disease Division, Department of Internal Medicine, St. Michael’s Medical Center, Newark, New Jersey)
,
Nevens Frederik
(Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Belgium)
,
Sigal Samuel
(Montefiore Medical Center, Bronx, New York)
,
Cohen Stanley
(UH Cleveland Medical Center, Cleveland, Ohio)
,
Fredrick Linda M.
(AbbVie, Inc, North Chicago, Illinois)
,
Pires dos Santos Ana Gabriela
(AbbVie, Inc, North Chicago, Illinois)
,
Rodrigues Lino
(AbbVie, Inc, North Chicago, Illinois)
,
Dillon John F.
(Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom)
資料名:
Clinical Gastroenterology and Hepatology
(Clinical Gastroenterology and Hepatology)
巻:
18
号:
11
ページ:
2544-2553.e6
発行年:
2020年
JST資料番号:
W3126A
ISSN:
1542-3565
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)